Drug intelligence / Profile preview

umbilical cord-derived mesenchymal stem cells (General Hospital of the Northern Theater Command)

Development stage
Unknown
Lead developer
General Hospital of the Northern Theater Command
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are a cell-based biologic therapy being developed by the General Hospital of Shenyang Military Region for the treatment of ischemic stroke. These multipotent stem cells are harvested from the umbilical cord and administered intravenously. The therapeutic mechanism is believed to involve a combination of immunomodulation, neuroprotection, and the promotion of neurogenesis and angiogenesis, largely mediated by the secretion of various neurotrophic factors. Clinical evaluation has focused on safety and efficacy in patients within six months of stroke onset, as well as potential applications in end-stage liver disease.

Other names
UC-MSCsUmbilical Cord-derived Mesenchymal Stem Cells

Beyond the preview

Go deeper on umbilical cord-derived mesenchymal stem cells (General Hospital of the Northern Theater Command).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord-derived mesenchymal stem cells (General Hospital of the Northern Theater Command).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call